About rituximab
Rituximab is a medicine known as a 'monoclonal antibody'.
It is licensed for treating various conditions in adults (aged 18 years and over) including non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, and granulomatosis with polyangiitis, or microscopic polyangiitis. It is not licensed for use in children. Rituximab is given by a drip (also known as an infusion) into a vein. This would usually be carried out in hospital by a doctor or nurse who has experience in using the treatment.
Rituximab is not licensed for treating ITP in children or adults, and so using it for ITP is 'off‑label'.
This page was last updated: